Literature DB >> 2548011

Human cytomegalovirus binding to fibroblasts is receptor mediated.

H P Taylor1, N R Cooper.   

Abstract

The binding of radiolabeled human cytomegalovirus (HCMV) strain AD169 to human lymphocytes, lymphoblastoid cell lines, monocytes, and fibroblasts varied over a 20-fold range. Since maximum binding was observed with human foreskin fibroblasts (HFF), interactions of radiolabeled HCMV with this cell type were analyzed quantitatively. Binding of HCMV to HFF at 4 degrees C was specific and saturable; at low viral inputs specific binding averaged 16.4% of input and nonspecific binding was less than 1% of input. Binding curves yielded single-component linear Scatchard plots indicating an average Kd of 1.1 nM and 5,262 available virus-binding sites per cell. A two-component Scatchard curve was obtained at 37 degrees C and reflected viral internalization, since it could be converted to a single-component curve by the use of paraformaldehyde-fixed cells. HCMV strain Towne was found to bind to the receptor used by HCMV strain AD169 with similar affinity. HCMV failed to bind to protease-treated HFF or to HFF grown in the presence of inhibitors of glycosylation. Sialic acid residues, however, were not found to be important in binding. These data indicate that a single type of molecule, likely a glycoprotein, on the surface of HFF serves as a specific receptor for the virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548011      PMCID: PMC250996          DOI: 10.1128/JVI.63.9.3991-3998.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies.

Authors:  I Sarov; I Abady
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

2.  Cytomegaloviremia in children with acute lymphocytic leukemia.

Authors:  F Cox; W T Hughes
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

3.  Detection of cytomegalovirus by ELISA in urine samples is inhibited by beta 2 microglobulin.

Authors:  J A McKeating; J E Grundy; Z Varghese; P D Griffiths
Journal:  J Med Virol       Date:  1986-04       Impact factor: 2.327

4.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

5.  Infectious complications of the acquired immune deficiency syndrome.

Authors:  J W Gold; D Armstrong
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

6.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

7.  Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response?

Authors:  J A McKeating; P D Griffiths; J E Grundy
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

8.  Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells.

Authors:  J E Grundy; J A McKeating; P D Griffiths
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

9.  Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.

Authors:  B Kari; N Lussenhop; R Goertz; M Wabuke-Bunoti; R Radeke; R Gehrz
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Interferon-gamma-dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes.

Authors:  I Esparza; R I Fox; R D Schreiber
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

View more
  20 in total

1.  An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus.

Authors:  L M Stannard; D R Hardie
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells.

Authors:  Arsham Banisadr; Yaghoub Safdari; Anvarsadat Kianmehr; Mahdieh Pourafshar
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

3.  General analysis of receptor-mediated viral attachment to cell surfaces.

Authors:  T J Wickham; R R Granados; H A Wood; D A Hammer; M L Shuler
Journal:  Biophys J       Date:  1990-12       Impact factor: 4.033

4.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines.

Authors:  M Herrmann; M Oppenländer; M Pawlita
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.

Authors:  C Söderberg; T D Giugni; J A Zaia; S Larsson; J M Wahlberg; E Möller
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Replication of human cytomegalovirus in the cells of the U937 monocytoid cell line.

Authors:  K Numazaki; N Nagata; T Sato; S Chiba
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

8.  Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts.

Authors:  P E Lobert; D Hober; A S Delannoy; P Wattré
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Expression of a human cytomegalovirus receptor correlates with infectibility of cells.

Authors:  D M Nowlin; N R Cooper; T Compton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection.

Authors:  M N Wykes; G R Shellam; J McCluskey; W M Kast; P B Dallas; P Price
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.